The Wall Street Journal
Health News
WSJ.com: Health
Health
Egg Inspectors Failed to Raise Alarms
U.S. Department of Agriculture experts found bugs and trash earlier this year on the Iowa farm at the center of the big recent egg recall, but didn't notify federal health authorities or delay production.
U.S. Rebukes Health Insurers
The Obama administration told health insurers that it will track those who enact "unjustified" rate increases and may block those companies from a new marketplace for insurance coverage.
FDA Warns E-Cigarette Makers
The FDA sent warning letters to five electronic-cigarette companies, saying they are violating federal law by marketing their products as tools to help people quit using cigarettes.
Elan Pulls SEC Into Spat
In an unusual twist to a boardroom spat at Elan, the Irish biotech firm has reported one of its own directors to regulators at the SEC for potential insider-trading allegations.
FDA Boosts Warnings On Drugs Used in MRIs
The FDA said certain types of drugs used in MRI scans shouldn't be used in patients with kidney disease because of the risk of developing a rare and potentially fatal skin condition.
Health Outlays Still Seen Rising
The health-care overhaul enacted last spring won't significantly change national health spending over the next decade compared with projections before the law was passed.
Roche Boosts China Presence
Roche is increasing its investments in China to accommodate the country's growing health-care needs, its chief executive said.
Glaxo Taps Banker as Finance Chief
GlaxoSmithKline chose Simon Dingemans, a Goldman Sachs M&A specialist, to be its next chief financial officer.
Insurers Pin Rate Hikes on Health Law
Insurers plan to raise premiums on some Americans as a result of the health overhaul as soon as next month, complicating Democrats' efforts to trumpet their signature achievement ahead of elections.
Bristol to Buy Biotech Company
Bristol-Myers Squibb Co. agreed to acquire biotechnology company ZymoGenetics Inc. for $735 million, in a move to strengthen its pipeline of drugs for hepatitis and other diseases.
Drug-Patent Decision Stands
A federal appeals court declined to reconsider its April ruling that upheld the legality of pharmaceutical-patent settlements that can delay the introduction of generic drugs.
J&J Seeks Remicade Damages
Johnson & Johnson is seeking damages from Merck as it negotiates to dissolve a partnership over the big-selling rheumatoid arthritis drug Remicade.
Purdue Pharma to Settle Oxycontin Claims
Purdue Pharma agreed to pay $16 million to settle a lawsuit by purchasers of Oxycontin over how it obtained patents on the painkiller in the 1990s.
Why Trainers Say, 'Slow Down'
Research shows injury rates rise as runners increase their weekly mileage. Personal trainers and coaches are now helping Type-A runners realize their limits.
Today is
